Form 8.5 (EPT/RI) - Spire Healthcare Group plc

Summary by AI BETAClose X

On 2 November 2026 an exempt principal trader acting in a client‑serving capacity reported purchases of 143,630 Spire Healthcare shares at GBP2.4800–2.4900 and sales of 462,358 shares at GBP2.4800–2.4950, a net sale of 318,728 shares; cash‑settled equity swap activity referenced 478,322 shares with a net decrease in long exposure of 55,353 and a net decrease in short exposure of 376,829, executed at prices around GBP2.48–2.495; no indemnities, option/voting arrangements or other dealing agreements were disclosed in the Form 8.5 filing made on 3 November 2026.

Disclaimer*

UK 100

Latest directors dealings